Exploring Adherence to First-Line and Second-Line Immunotherapies in Multiple Sclerosis: An Interview Study

BACKGROUND: Treatment adherence is fundamental in multiple sclerosis (MS) management. Adherence rates vary significantly between studies, ranging from 30% to almost 90%, depending on assessment method and medication type. This study aimed to identify patient-related categories associated with treatm...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J MS Care
Asıl Yazarlar: Pust, Gesa E.A., Untiedt, Benthe, Randerath, Jennifer, Barabasch, Anna, Köpke, Sascha, Rahn, Anne C., Hansen, Hilke, Heesen, Christoph
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: The Consortium of Multiple Sclerosis Centers 2020
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7643847/
https://ncbi.nlm.nih.gov/pubmed/33177958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7224/1537-2073.2018-068
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller